Commission Delegated Regulation (EU) 2024/1701 of 11 March 2024 amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
018/2025
In force in the EEA
Yes
Legal Documents
Commission Delegated Regulation (EU) 2024/1701 of 11 March 2024 amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use
Framseld reglugerð framkvæmdastjórnarinnar (ESB) 2024/1701 frá 11. mars 2024 um breytingu á reglugerð (EB) nr. 1234/2008 að því er varðar athugun á breytingum á skilmálum markaðsleyfa fyrir mannalyfjum
Delegierte Verordnung (EU) 2024/1701 der Kommission vom 11. März 2024 zur Änderung der Verordnung (EG) Nr. 1234/2008 über die Prüfung von Änderungen der Zulassungen von Humanarzneimitteln
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.